Cargando…
Exploiting GRK2 Inhibition as a Therapeutic Option in Experimental Cancer Treatment: Role of p53-Induced Mitochondrial Apoptosis
SIMPLE SUMMARY: The involvement of GRK2 in cancer growth and an inverse correlation with p53 levels were suggested in breast cancer. Furthermore, increased GRK2 expression and activity were detected in thyroid cancer, but its effects and mechanisms of action were not investigated yet. This study aim...
Autores principales: | Gambardella, Jessica, Fiordelisi, Antonella, Santulli, Gaetano, Ciccarelli, Michele, Cerasuolo, Federica Andrea, Sala, Marina, Sommella, Eduardo, Campiglia, Pietro, Illario, Maddalena, Iaccarino, Guido, Sorriento, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760517/ https://www.ncbi.nlm.nih.gov/pubmed/33256128 http://dx.doi.org/10.3390/cancers12123530 |
Ejemplares similares
-
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization.
por: Sorriento, Daniela, et al.
Publicado: (2014) -
The Metabolic Role of GRK2 in Insulin Resistance and Associated Conditions
por: Sorriento, Daniela, et al.
Publicado: (2021) -
Antidiabetic and Cardioprotective Effects of Pharmacological Inhibition of GRK2 in db/db Mice
por: Cipolletta, Ersilia, et al.
Publicado: (2019) -
The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors
por: Sorriento, Daniela, et al.
Publicado: (2018) -
GRKs and β-Arrestins: “Gatekeepers” of Mitochondrial Function in the Failing Heart
por: Sorriento, Daniela, et al.
Publicado: (2019)